Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

A new method was developed to measure and assess the activity and inhibition of the enzyme steroid 5α-reductase.

Activated protein C helps protect mice from radiation damage.

Aire mutation reduces alopecia areata, while Notch4 mutation prevents it in mice.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

Ciproterone acetate improves hair regrowth and acne in most female patients.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Upadacitinib effectively treats pyoderma gangrenosum.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Start with 2.5 mg/mL triamcinolone acetonide for scalp alopecia areata and increase if needed.

Precise objectives can improve student achievement in health education.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

Baricitinib was effective in treating both early and late onset alopecia areata.

N-acetyl-cysteine improves hair growth and is safe for treating early male hair loss.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

Blocking CXXC5 speeds up diabetic wound healing by improving blood vessel growth and skin repair.

Activated protein C helps protect mice from long-term radiation damage.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.